• LLS Launches Online Video on How to Join Clinical Trials, What to Expect
  • Humalutin Inhibits Tumor Growth in Non-Hodgkin’s Lymphoma, Preclinical Study Shows
  • New DLBCL Genetic Subtypes Offer Potential for Tailored Therapies, Researchers Say
  • Blocking a MicroRNA Improves Symptoms of Chronic Graft-versus-Host Disease in Mouse Model
  • Hepatitis B Infection Increases Risk of Non-Hodgkin’s Lymphoma, Research Shows
  • FDA Grants Priority Review to Duvelisib for Two Lymphoma Types
  • Tenalisib Receives FDA Orphan Drug Status for Treatment of Cutaneous T-cell Lymphoma
  • Phase 2b Trial of Betalutin in Relapsed Follicular Lymphoma Patients on Track, Nordic Says
  • First Patient Dosed in Phase 3 Trial of Denovo’s DB102 Plus Chemo for High-risk DLBCL
  • Bioniz Recruiting Patients for Phase 1/2 Trial of Its Leukemia and Lymphoma Therapy
  • Telo-HL Scoring Model Developed to Predict Relapse Risk in Hodgkin’s Patients, 3DS Says
  • Fatigue Levels Higher, Endurance Lower for Cancer Survivors, Study Finds